International Clinical Trial: A retrospective study on the efficacy and safety of yttrium-90 versus conventional transcatheter arterial chemoembolization (TACE) combined with target immunotherapy in the treatment of unresectable hepatocellular carcinoma

Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119069) titled 'A retrospective study on the efficacy and safety of yttrium-90 versus conventional transcatheter arterial chemoembolization (TACE) combined with target immunotherapy in the treatment of unresectable hepatocellular carcinoma' on Feb. 14.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of Army Medical University

Condition: hepatocellular carcinoma (HCC)

Intervention: Single yttrium-90 treatment group:None TACE combined with target therapy and timmunotherapy group:None Single TACE group treatment group:None

Recruitment Status: Not Recruiting

Phase: ...